Pharmaceutical Applications of the Polarizable Amoeba Potential, Including Protein-Ligand Binding Affinity and Drug Solubility, using the Force Field X Software  by Schnieders, Michael J. et al.
Tuesday, February 28, 2012 409aCardiac contraction is triggered when a membrane depolarisation induces
a massive increase in intracellular calcium concentration. This process called
‘‘excitation-contraction (E-C) coupling’’ relies on a multimolecular protein
complex, the calcium release complex (CRC) organized around the sarcoplas-
mic reticulum calcium channel, the ryanodine receptor (RyR2). Among the
proteins involved in the efficient function of the CRC, calsequestrin, triadin
and junctin are sarcoplasmic reticulum proteins able to interact with RyR2
and regulate calcium release.
Mutations in RyR2 and calsequestrin are associated to a rare but fatal cardiac
arrhythmia: catecholaminergic polymorphic ventricular tachycardia (CPVT).
Nevertheless, variations in these two genes (RYR2 and CASQ2) account so
far for only 50 to 70% of the cases, suggesting that other genes are most prob-
ably involved. To reveal new genes involved in CPVT, we have based a can-
didate gene approach on the hypothesis that the pathology could be considered
as a disease of the calcium release complex. We therefore searched for vari-
ations in the genes encoding proteins of the CRC in a large French cohort of
CPVT patients with no detected mutations in RYR2 or CASQ2. We have
identified for the first time mutations in the human triadin gene TRDN, and
studied the functional consequences of a missense mutation both in a cell
model and in vivo after expression in triadin KO mice. Our results confirmed
the hypothesis that CPVT can be more generally considered as a defect in
the CRC.
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Atrial fibrillation (AF), or conditions conducive to it, often occur(s) in conjunc-
tion with high and/or unbalanced sympathetic/parasympathetic (autonomic) ac-
tivity, which has profound effects on myocyte Ca2þ cycling. Using confocal
microscopy, we have begun scrutinizing the effects various autonomic
agents–including but not limited to isoproterenol (ISO; *-adrenergic receptor
(AR) agonist), phenylephrine (PE; *-AR agonist) norepinephrine (NE, *- and
*-AR agonist), and carbachol (CCh; muscarinic cholinergic receptor ago-
nist)–have on Ca2þ cycling in isolated canine atrial myocytes paced at cycle
lengths (CLs) ranging from 5000-200ms. In general, Ca-transient amplitudes
were increased by ISO and NE; decreased by CCh; and varying decreased, in-
creased or unaffected by PE–although PE only increased Ca-transients after
PTX-treatment. However, considerable cell-to-cell variability in magnitude/
dose-response for such effects was notable. The effects these agents had on ir-
regular Ca-release events (ICREs)–i.e., Ca-alternans triggered-Ca-waves oc-
curring during pacing (t-CaWs), and spontaneous-Ca-waves occurring during
a pause after pacing (s-CaWs)–consequent to rapid pacing (CLs%300ms)
were interestingly distinct. CCh significantly reduced the appearance of all
ICREs, yet were often accentuated upon CCh withdrawal. ISO often induced
s-CaWs, but suppressed t-CaWs–with Ca-alternans often appearing in their
stead. NE mimicked ISO regarding ICREs in some cells, but in others did
not suppress and sometimes accentuated t-CaWs. PE accentuating t-CaWs
and/or subcellular Ca-alternans in some cells, while suppressing or having no
apparent effect on them in others. However, after PTX-treatment, PE mimicked
ISO regarding ICREs without s-CaWs induction. These findings not only un-
derscore the complexity of atrial autonomic modulation and its differences
with that in ventricle, but also particulars evident only during rapid pacing–
i.e., that during or conducive to the onset of AF.
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PIP2 is a precursor of important second messengers, and by itself is a direct
modulator of the activity of ion channels and transporters. We investigated
the localization and dynamic changes in PIP2 levels in live adult muscle fi-
bers by expressing two PIP2 sensors: an EGFP construct of the pleckstrin ho-
mology (PH) domain of the phospholipase delta1 subunit (PH-EGFP), and
a construct of the PIP2 binding domain of the tubby protein (EGFP-tubby).
EGFP-tubby has higher affinity and specificity for PIP2 than PH-EGFP, and
has been used to sequester PIP2 in the plasma membrane. Their respective
plasmids (*) were transfected by in vivo electroporation of FDB muscles.
Two-photon laser scanning microscopy (TPLSM) shows that both EGFP-
tubby and PH-EGFP are efficiently expressed in muscle fibers and that
they are distributed in a double-banded pattern indicating localization atthe transverse tubular system (TTS) membranes (in addition to the sarco-
lemma). Peak/baseline ratio analysis of TPLSM images suggests that there
is a larger proportion of EGFP-tubby than PH-EGFP associated with the
TTS membranes. Although the expression of PH-EGFP does not change nei-
ther the voltage-dependence nor the amplitude of Ca2þ release signals de-
tected with Rhod-5N, the expression of EGFP-tubby apparently left-shifts
their voltage-dependence by >10 mV. To further investigate the localization
and dynamics of PIP2 in the TTS, we performed fluorescence resonance en-
ergy transfer (FRET) studies. The voltage-dependence of FRET signals,
based on the translocation of the lipophilic anion dipicrylamine (DPA), shows
that the EGFP tags of both PH-EGFP and EGFP-tubby are anchored within
~6-9 nm of the TTS membrane. (*)The plasmids were kindly provided to
us by Dr. Tamas Balla, NICHD, NIH. This work was supported by NIH
grants AR047664, AR041802, and AR054816.
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Previous studies from our laboratory have shown that weakness, rather than de-
creased endurance, is the main contractile defect in a mouse mitochondrial my-
opathy model (skeletal muscle-specific Tfam KO mice). Here we used a mouse
model with mitochondrial defects induced by knock-in of a proof-reading-
deficient version of PolgA. These mice display an increased number of muta-
tions in the mitochondrial DNA (mtDNA) and a premature aging phenotype.
In this study we measured force and free cytosolic [Ca2þ] ([Ca2þ]i) in isolated
fast-twitch flexor digitorum brevis fibers of 5 month old mice; at this age the
mtDNA mutator mice show no general signs of malfunction. In the unfatigued
state, there was no difference in force or [Ca2þ]i between mtDNA mutator and
control muscle fibers. However, during fatigue induced by repeated tetanic con-
tractions, force and tetanic [Ca2þ]i declined more rapidly in mtDNA mutator
than in control muscle fibers. Muscles of mtDNA mutator mice also showed
several signs of impaired mitochondrial function: decreased activity of citrate
synthase and 3-hydroxyacyl-CoA dehydrogenase and decreased protein expres-
sion of PGC-1a and cytochrome c oxidase-1. In conclusion, decreased endur-
ance due to impaired mitochondrial respiration is an early sign of muscle
dysfunction in mtDNA mutator mice.
Platform: Protein-Ligand Interactions
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In the derivation of any knowledge-based scoring function, one must decide
how to manage sparse features in the training data. Here we present STScore,
a distance-dependent set of atomic pair potentials that uses a novel approach to
minimize the sparse data problem. The overall approach is to represent the ac-
tual potential of mean force, which is unknown, as a random variable whose
probability density is determined by the evidence in the training set. This pro-
vides a natural way of representing the uncertainty in the potential of mean
force (PMF), for each bin and atom pair type. STScore is an average of the
PMF and an alternative force-field-based potential, with the weights chosen
to minimize the error in the sum. This weighting scheme implies that STScore
will give more weight to the force-field potential whenever training data is
scarce. We show that STScore effectively combines the two alternatives, ex-
ceeding the performance of either potential alone, and leads to improved bind-
ing mode and binding affinity predictions.
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Accurate prediction of protein-ligand binding affinity is essential to computa-
tional drug discovery. Although virtual screening has been widely utilized, cur-
rent approaches are seriously limited by the accuracy of the underlying
potential energy model (i.e. force field) that describes atomic interactions. A
410a Tuesday, February 28, 2012more rigorous physical model combined with effective sampling of molecular
configurations is critical for binding affinity prediction to chemical accuracy,
which is defined as within one order of magnitude of the true equilibrium dis-
sociation constant. We have demonstrated that electrostatic interactions, espe-
cially electronic polarization, are critical for protein-ligand recognition due to
the significant change in electrostatic environments between bulk water and
protein pockets and have achieved encouraging success in treating charged spe-
cies using the polarizable Atomic Multipole Optimized Energetics for Biomo-
lecular Applications (AMOEBA) force field. To maintain accuracy while also
achieving efficiency, AMOEBA has been combined with the Orthogonal Space
Random Walk en-
hanced alchemical
free energy algo-
rithm. Here we pres-
ent applications of
this strategy for the
computation of pro-
tein-ligand binding
affinities and, for the
first time, drug solu-
bility from alchemi-
cal simulations using
the Force Field X
software.2083-Plat
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Many ion channels such as the MloK1 channel are steered by ligand binding via
conformational changes. Mainly two binding mechanisms have been proposed,
induced fit and conformational selection. Using molecular dynamics simula-
tions, we studied ligand binding of cyclic adeonise monophosphate at the cyclic
nucleotide binding domain of the MloK1 ion channel of Mesorizobium loti. For
this binding domain, both crystal and NMR structures have been determined for
both the ligand free as well as for the ligand bound conformation.
In the simulations, spontaneous binding was observed, which enabled us to de-
termine reaction coordinates for the ligand binding as well as for the associated
conformational change of the protein. We used a combination of force probe
simulations, umbrella sampling, and unbiased simulations to determine poten-
tials of mean force along these reaction coordinates, transition rates, as well as
free energy differences and barriers between the most relevant substates.
Our results are compared with measured affinities and kinetics, and suggest an
induced fit-mechanism.
2084-Plat
Pathway and Mechanism of Drug Binding to G-Protein-Coupled Recep-
tors
Ron O. Dror1, Albert C. Pan1, Daniel H. Arlow1, David W. Borhani1,
Paul Maragakis1, Yibing Shan1, Huafeng Xu1, David E. Shaw1,2.
1D E Shaw Research, New York, NY, USA, 2Center for Biology and
Bioinformatics, Columbia University, New York, NY, USA.
How drugs bind to their receptors—from initial association, through entry into
the binding pocket, to adoption of the final bound pose—has remained un-
known, even for G-protein-coupled receptor modulators, which constitute
one-third of all drugs. We captured this pharmaceutically critical process in
atomic detail using the first unbiased molecular dynamics simulations in which
drug molecules spontaneously associate with G-protein-coupled receptors to
achieve final poses matching those determined crystallographically (PNAS
108:13118 (2011)). We found that several beta blockers and a beta agonist
all traverse the same dominant pathway as they bind to the b1- and b2-adrener-
gic receptors, initially associating with a vestibule on
each receptor’s extracellular surface. Surprisingly, this
association, at a distance of 15 A˚ from the binding
pocket, often presents the largest energetic barrier to
binding, despite the fact that subsequent entry into the
pocket requires the receptor to deform and the drug to
squeeze through a narrow passage. The early barrier
may reflect the substantial dehydration that occurs as
the drug associates with the vestibule. Our atomic-level
description of the binding process suggests opportunities
for allosteric modulation and provides a structural foun-
dation for future optimization of binding and unbinding
rates.2085-Plat
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The active components of animal venoms are potentially useful in many elec-
trophysiological and pharmacological applications due to their highly selective
nature. Of this rich concoction, the binding mechanisms of many toxin types
remain to be elucidated. We therefore present a preliminary method to deduce
the selectivity profile of a peptide toxin against related channels by means of
docking simulations. This is tested on the family of a-KTx scorpion toxins,
for which structural and limited affinity data are available for over 20 toxins
across seven sub-families. Docking simulations against Kv1.1, Kv1.2 and
Kv1.3 were carried out under both blind-docking trials and common-lysine-
motif trials, using the program HADDOCK.
This study reports on a selection of toxins for which validation can be best pro-
vided, given current limitations of docking accuracy. The general selectivity
profiles of toxin-subfamilies can be deduced via consensus between closely re-
lated toxin-channel pairings. In particular, HADDOCK was able to classify
a-KTX2 toxins as universal binders and a-KTX3 toxins as Kv1.3-selective
binders. An estima-
tion of individual se-
lectivity profiles can
be further deduced by
program performance.
This method is ex-
pected to be useful in
the refinement of
toxins for channel-
subtype targetting.2086-Plat
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Virus ion channels are small (3-15 kD) peptides that aggregate to form ion
channels that are important for viral infection1. As viruses continue to pose
a major worldwide health problem, these ion channels represent an exciting
new target for therapeutic intervention. Viral ion channels that have been pre-
viously identified include Vpu of the human immunodeficiency virus (HIV) and
P7 of Hepatitis C however it is the M2 influenza A protein that represents the
best exploited ion channel drug target so far.
The proton-selective M2 ion channel is the target of the adamantane family of
drug inhibitors. Use of the two most common adamantane inhibitors, amanta-
dine and rimantadine have declined steadily over recent years due to the emer-
gence of adamantane-resistant flu strains. We have conducted a series of
surface plasmon resonance experiments designed to measure the affinity be-
tween several ion channel inhibitors and M22. By examining drug binding to
a number of mutant M2 constructs (derived from adamantane-resistant strains),
it was possible to establish the location of the drug binding sites and to ratio-
nalise the effect on drug binding of specific mutant residues. In light of these
results, the prospect for future development of a new generation of M2 inhib-
itors will be discussed. Moreover, we explore the possibility of expanding this
field of research to incorporate ion channel proteins from other viruses.
1. Gonzalez, M and Carrasco, L (2003). FEBS Lett. (2003) 552(1):28-34.
2. Rosenberg, M and Casarotto, M (2010) PNAS 107(31):13866-71.
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Small molecule kinase inhibitors have recently demonstrated dramatic po-
tential for treating cancers caused by dysregulated protein kinases. The ef-
ficacy of these compounds is due to their ability to selectively target
particular protein kinases, and this selectivity is remarkable given the fact
that they bind to the ATP-binding site of the kinase domain, which is highly
conserved in sequence across this large protein family. The origin of this
selectivity is unknown, but must relate to differences in physical properties
of the ATP-binding site among members of this protein family. The goal of
this project is to assess how the evolutionary divergence of sequence and
structure in the human kinome translates into variation in ATP-binding
site electrostatics, and how this variation can be exploited to design highly
selective inhibitors. I am using a clinically important class of kinase
